Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Buy
+2,800
New +$271K ﹤0.01% 11313
2025
Q2
– Sell
-1,800
Closed -$210K – 13201
2025
Q1
$210K Sell
1,800
-200
-10% -$24.4K ﹤0.01% 10354
2024
Q4
$240K Sell
2,000
-1,100
-35% -$133K ﹤0.01% 10114
2024
Q3
$330K Sell
3,100
-300
-9% -$29.7K ﹤0.01% 9136
2024
Q2
$321K Sell
3,400
-100
-3% -$10.4K ﹤0.01% 8997
2024
Q1
$387K Buy
3,500
+1,878
+116% +$175K ﹤0.01% 8926
2023
Q4
$140K Sell
1,622
-3,900
-71% -$296K ﹤0.01% 10484
2023
Q3
$388K Buy
5,522
+3,300
+149% +$230K ﹤0.01% 8620
2023
Q2
$148K Buy
2,222
+900
+68% +$54.6K ﹤0.01% 10363
2023
Q1
$78.1K Sell
1,322
-593
-31% -$34K ﹤0.01% 11592
2022
Q4
$89.9K Buy
+1,915
New +$80.1K ﹤0.01% 11365

Other funds holding ESAB

Citadel Advisors's ESAB Position: Q2 2026 in Review

Citadel Advisors opened a new position in ESAB (ESAB) in Q2 2026: 41,650 shares worth $4.11M. The stake represents ﹤0.01% of the portfolio and ranks #5078 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in ESAB as recently as Q4 2025.

Citadel Advisors first reported a position in ESAB in Q2 2022 and has held it in 14 quarters since. The position peaked at $17.9M in Q4 2025. 347 funds tracked by Wall St. Rank hold ESAB as of Q2 2026.

  • Citadel Advisors held 41,650 shares of ESAB worth $4.11M as of Q2 2026.
  • ESAB was a new Citadel Advisors position in Q2 2026.
  • ESAB made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5078 holding.
  • Citadel Advisors first reported a position in ESAB in Q2 2022 and has held it in 14 quarters since.
  • Citadel Advisors's ESAB position peaked at $17.9M in Q4 2025.
  • 347 funds tracked by Wall St. Rank held ESAB as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.